ultiva
Generic: remifentanil hydrochloride
Labeler: mylan institutional llcDrug Facts
Product Profile
Brand Name
ultiva
Generic Name
remifentanil hydrochloride
Labeler
mylan institutional llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
remifentanil hydrochloride 1 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
72078-036
Product ID
72078-036_594087a1-25f2-4f68-aea6-ad7df40559ab
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA020630
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2024-12-16
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72078036
Hyphenated Format
72078-036
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ultiva (source: ndc)
Generic Name
remifentanil hydrochloride (source: ndc)
Application Number
NDA020630 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1 mg/mL
Packaging
- 10 VIAL, GLASS in 1 CARTON (72078-036-05) / 10 mL in 1 VIAL, GLASS (72078-036-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "594087a1-25f2-4f68-aea6-ad7df40559ab", "openfda": {"unii": ["5V444H5WIC"], "rxcui": ["1729578", "1729581", "1729584", "1729586", "1729710", "1729712"], "spl_set_id": ["8b4c8696-e23e-4c51-a4d2-babab5bd945a"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (72078-036-05) / 10 mL in 1 VIAL, GLASS (72078-036-00)", "package_ndc": "72078-036-05", "marketing_start_date": "20241216"}], "brand_name": "Ultiva", "product_id": "72078-036_594087a1-25f2-4f68-aea6-ad7df40559ab", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "72078-036", "dea_schedule": "CII", "generic_name": "Remifentanil Hydrochloride", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ultiva", "active_ingredients": [{"name": "REMIFENTANIL HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "NDA020630", "marketing_category": "NDA", "marketing_start_date": "20241216", "listing_expiration_date": "20261231"}